Second, Pfizer's forward dividend yield stands at 7.47%. At first glance, the drugmaker's dividend payout ratio of 122.5% ...

Here is why Pfizer can't seem to get off the mat and whether it's worth buying the dip on today. I won't rehash Pfizer's pandemic journey too much. The company developed and sold a vaccine (Comirnaty) ...

Provident Financial Services shows strong loan growth potential, stable margins, and a 5.8% yield despite market headwinds.

Pfizer (NYSE:PFE) recently presented groundbreaking findings in cancer research, particularly the first-in-human Phase 1 clinical study of the innovative MesoC2 drug at the ASCO Annual Meeting, and ...

Roche's Itovebi combo gains EMA panel endorsement for advanced breast cancer with PIK3CA mutation. Read more here.

Tvardi Therapeutics Inc. stock grades by Barron's. View TVRD fundamental and sentiment analysis powered by MarketGrader.